Mabion S.A.
Stock Exchange Warsaw Stock Exchange
EPS
PLN5.16
Market Cap
PLN1.16 B
Shares Outstanding
13.72 M
Public Float
7.51 M

Profile

Address
ul. gen. Mariana Langiewicza 60
Konstantynów Lódzki LD 95
Poland
Employees -
Website http://www.mabion.eu
Updated 07/08/2019
Mabion SA is a biotechnology company, which engages in the development and manufacturing of biotech drugs. Its products, which are based on humanized monoclonal antibodies, are used for the treatment of cancer and metabolic diseases. It also involved research in the field of biotechnology.

Financials

View All
Created with Highcharts 5.0.14Mabion S.A.Net Income. Fiscal year is January-December. All values PLN Thousands.3 8913 8914 4614 46142 54142 54155 82655 82657 88757 88768 87068 870201320142015201620172018020k40k60k80k
Created with Highcharts 5.0.14Mabion S.A.Sales/Revenue. Fiscal year is January-December. All values PLN Thousands.558308302 7332 733000010 66210 66220132014201520162017201802.5k5k7.5k10k12.5k

Jacek Piotr Nowak
Member-Supervisory Board
Maciej Wieczorek
Deputy Chairman-Supervisory Board